Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab-Reference-Cited by-同舟云学术

Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab

Published:2018-09-19 Issue:1 Volume:47 Page:59-65
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Zappulo Emanuela,Nicolini Laura Ambra,Di Grazia Carmen,Dominietto Alida,Lamparelli Teresa,Gualandi Francesca,Caligiuri Patrizia,Bruzzone Bianca,Angelucci Emanuele,Viscoli Claudio,Mikulska Malgorzata

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s15010-018-1214-5/fulltext.html

Reference31 articles.

1. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991;100:182–8.

2. Chemin I, Jeantet D, Kay A, Trepo C. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(−) liver disease. Antivir Res. 2001;52:117–23.

3. Etzion O, Ghany MG. Screening for hepatitis B virus to prevent viral reactivation—who and when? Clin Liver Dis. 2015;5:47–50. https://doi.org/10.1002/cld.458 .

4. EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–98. https://doi.org/10.1016/j.jhep.2017.03.021 .

5. Mallet V, van Bommel F, Doerig C, Pischke S, Hermine O, Locasciulli A, et al. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis. 2016;16:606–17. https://doi.org/10.1016/s1473-3099(16)00118-3 .

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer Immunomodulators;Current Hepatology Reports;2024-02-28

2. Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country;European Journal of Internal Medicine;2023-02

3. Viral hepatitis B in patients with hematological malignancies (Overview);Archives of Hepatitis Research;2023-01-30

4. Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion;Journal of Hepatology;2022-12

5. Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-07